We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Equinox Gold
EQX
$7.32B
| $198K | ﹤0.01% |
34,451
-2,685
| -7% | -$17.4K |
|
3227
Integra LifeSciences
IART
$1.54B
| $198K | ﹤0.01% |
16,123
-1,129
| -7% | -$16.4K |
|
3228
Ericsson
ERIC
$30.7B
| $198K | ﹤0.01% |
23,295
-7,951
| -25% | -$65.3K |
|
3229
Compañía de Minas Buenaventura
BVN
$7.85B
| $196K | ﹤0.01% |
11,958
-809
| -6% | -$12.3K |
|
3230
CALL
Target
TGT
$62.1B
| $196K | ﹤0.01% |
50,000
| – | – |
|
|
CHCT
3231
Community Healthcare Trust
CHCT
$537M
| $196K | ﹤0.01% |
+11,756
| New | +$194K |
|
3232
Newell Brands
NWL
$2.16B
| $195K | ﹤0.01% |
36,163
-21,925
| -38% | -$116K |
|
3233
Krispy Kreme
DNUT
$543M
| $195K | ﹤0.01% |
67,074
+57,036
| +568% | +$199K |
|
3234
Acco Brands
ACCO
$369M
| $195K | ﹤0.01% |
54,421
+18,924
| +53% | +$70K |
|
3235
Compass
COMP
$8.27B
| $195K | ﹤0.01% |
31,014
-13,302
| -30% | -$91.1K |
|
3236
Plug Power
PLUG
$2.92B
| $194K | ﹤0.01% |
130,486
-21,248
| -14% | -$21.2K |
|
3237
Amneal Pharmaceuticals
AMRX
$5.72B
| $193K | ﹤0.01% |
23,896
+9,136
| +62% | +$68.9K |
|
|
EOT
3238
Eaton Vance National Municipal Opportunities Trust
EOT
$267M
| $193K | ﹤0.01% |
11,882
| – | – |
|
3239
Treace Medical Concepts
TMCI
$259M
| $193K | ﹤0.01% |
32,809
-6,132
| -16% | -$40K |
|
3240
Viasat
VSAT
$9.79B
| $191K | ﹤0.01% |
13,103
+2,212
| +20% | +$22.4K |
|
3241
Vir Biotechnology
VIR
$1.47B
| $190K | ﹤0.01% |
37,759
+25,760
| +215% | +$138K |
|
|
OPRA
3242
Opera Ltd
OPRA
$1.65B
| $189K | ﹤0.01% |
+10,021
| New | +$172K |
|
3243
Cytek Biosciences
CTKB
$576M
| $189K | ﹤0.01% |
55,677
+45,652
| +455% | +$152K |
|
3244
Evolv Technologies
EVLV
$943M
| $189K | ﹤0.01% |
+30,298
| New | +$140K |
|
3245
OppFi
OPFI
$770M
| $188K | ﹤0.01% |
+13,418
| New | +$151K |
|
3246
Calamos Strategic Total Return Fund
CSQ
$3.21B
| $187K | ﹤0.01% |
+10,250
| New | +$170K |
|
3247
Nurix Therapeutics
NRIX
$2.43B
| $187K | ﹤0.01% |
+16,409
| New | +$177K |
|
|
PBT
3248
Permian Basin Royalty Trust
PBT
$1.36B
| $187K | ﹤0.01% |
14,995
+1,903
| +15% | +$20.2K |
|
3249
Ponce Financial Group
PDLB
$489M
| $186K | ﹤0.01% |
13,439
-103
| -0.8% | -$1.33K |
|
|
ORC
3250
Orchid Island Capital
ORC
$1.31B
| $185K | ﹤0.01% |
26,455
-14,307
| -35% | -$99.2K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.